• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors.新诊断多发性骨髓瘤患者的全血黏度及白蛋白/纤维蛋白原比值计算:与部分预后预测指标的关系
Biomedicines. 2023 Mar 21;11(3):964. doi: 10.3390/biomedicines11030964.
2
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma.根据新诊断多发性骨髓瘤的预后预测因子,RDW 的变化。
Sci Rep. 2024 Feb 3;14(1):2832. doi: 10.1038/s41598-024-53385-6.
3
Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey.意义未明的单克隆丙种球蛋白病患者和多发性骨髓瘤患者全血粘度测量值与计算值的比较:对我们调查的重新评估
Clin Hemorheol Microcirc. 2021;79(3):475-483. doi: 10.3233/CH-211198.
4
Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.不同免疫化学类型多发性骨髓瘤中免疫球蛋白重/轻链对(Hevylite)差异、选定实验室参数与分层系统之间的关系
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):84-93. doi: 10.5507/bp.2015.032. Epub 2015 Aug 4.
5
Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma.新诊断多发性骨髓瘤患者队列的血栓风险和计算全血黏度。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296231222477. doi: 10.1177/10760296231222477.
6
Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases.通过激光衍射法评估多发性骨髓瘤患者的红细胞变形能力概况:对我们病例的重新检查。
Microvasc Res. 2023 Mar;146:104473. doi: 10.1016/j.mvr.2022.104473. Epub 2022 Dec 30.
7
Erythrocyte deformability and hemorheological profile in multiple myeloma.多发性骨髓瘤中的红细胞变形性和血液流变学特征
Clin Hemorheol Microcirc. 2018;68(1):25-34. doi: 10.3233/CH-170267.
8
Investigation of hemorheological parameters in periodontal diseases.牙周疾病血液流变学参数的研究。
Clin Hemorheol Microcirc. 2015;61(1):47-58. doi: 10.3233/CH-141892.
9
Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.用于评估多发性骨髓瘤患者肿瘤负荷的定量全身磁共振成像:与预后生物标志物的相关性
Quant Imaging Med Surg. 2021 Aug;11(8):3767-3780. doi: 10.21037/qims-20-1361.
10
Assessment of Red Blood Cell Distribution Width and Multiple Myeloma in a Guangxi Population: a Retrospective Study.广西人群中红细胞分布宽度与多发性骨髓瘤的评估:一项回顾性研究
Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180738.

引用本文的文献

1
Fibrinogen-to-albumin ratios are related to mortality in patients with secondary malignant neoplasm of bone and bone marrow.纤维蛋白原与白蛋白比值与骨和骨髓继发性恶性肿瘤患者的死亡率相关。
Heliyon. 2023 Jul 28;9(8):e18797. doi: 10.1016/j.heliyon.2023.e18797. eCollection 2023 Aug.

本文引用的文献

1
Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases.通过激光衍射法评估多发性骨髓瘤患者的红细胞变形能力概况:对我们病例的重新检查。
Microvasc Res. 2023 Mar;146:104473. doi: 10.1016/j.mvr.2022.104473. Epub 2022 Dec 30.
2
Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification.临床列线图在多发性骨髓瘤患者总生存和无事件生存预测中的应用:预后分层的可视化工具。
Front Public Health. 2022 Oct 17;10:958325. doi: 10.3389/fpubh.2022.958325. eCollection 2022.
3
Red Blood Cell Deformability and Distribution Width in Patients with Hematologic Neoplasms.血液肿瘤患者的红细胞变形能力和分布宽度。
Clin Lab. 2022 Oct 1;68(10). doi: 10.7754/Clin.Lab.2022.211260.
4
Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis.RDW 是否是新诊断多发性骨髓瘤的临床相关预后因素?系统评价和荟萃分析。
BMC Cancer. 2022 Jul 19;22(1):796. doi: 10.1186/s12885-022-09902-9.
5
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).多发性骨髓瘤早期死亡的预测因素:来自澳大利亚和新西兰骨髓瘤及相关疾病登记处(MRDR)的结果。
Br J Haematol. 2022 Sep;198(5):830-837. doi: 10.1111/bjh.18324. Epub 2022 Jul 11.
6
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.修订版国际分期系统(R2-ISS)在多发性骨髓瘤整体生存中的应用:Harmony 项目下欧洲骨髓瘤网络(EMN)的报告。
J Clin Oncol. 2022 Oct 10;40(29):3406-3418. doi: 10.1200/JCO.21.02614. Epub 2022 May 23.
7
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting.新诊断多发性骨髓瘤治疗前及治疗期间的风险分层:从临床试验到真实世界环境
Front Oncol. 2022 Mar 9;12:830922. doi: 10.3389/fonc.2022.830922. eCollection 2022.
8
The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment.亚铁调素-25 在肾功能损害的多发性骨髓瘤患者贫血中的关键作用。
Medicina (Kaunas). 2022 Mar 11;58(3):417. doi: 10.3390/medicina58030417.
9
Knowns and Unknowns about CAR-T Cell Dysfunction.嵌合抗原受体T细胞(CAR-T)功能障碍的已知与未知
Cancers (Basel). 2022 Feb 21;14(4):1078. doi: 10.3390/cancers14041078.
10
Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma.纳入细胞因子的预后列线图用于预测初诊多发性骨髓瘤患者的总生存。
Int Immunopharmacol. 2021 Oct;99:108016. doi: 10.1016/j.intimp.2021.108016. Epub 2021 Aug 9.

新诊断多发性骨髓瘤患者的全血黏度及白蛋白/纤维蛋白原比值计算:与部分预后预测指标的关系

Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors.

作者信息

Carlisi Melania, Lo Presti Rosalia, Mancuso Salvatrice, Siragusa Sergio, Caimi Gregorio

机构信息

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.

Department of Psychology, Educational Science and Human Movement, University of Palermo, 90127 Palermo, Italy.

出版信息

Biomedicines. 2023 Mar 21;11(3):964. doi: 10.3390/biomedicines11030964.

DOI:10.3390/biomedicines11030964
PMID:36979941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10045865/
Abstract

BACKGROUND

In this single center study, we retrospectively evaluated the calculated hemorheological profile in patients with a new diagnosis of multiple myeloma, with the aim to evaluate possible relationships with some prognostic predictors, such as ISS, albumin levels, beta2-microglobulin, red cell distribution width, and bone marrow plasma cell infiltration.

METHODS

In a cohort of 190 patients, we examined the calculated blood viscosity using the de Simone formula, and the albumin/fibrinogen ratio as a surrogate of erythrocyte aggregation, and then we related these parameters to prognostic factors, using the Kruskal-Wallis and the Mann-Whitney tests, respectively.

RESULTS

From our analysis, it emerged that the evaluated hemorheological pattern differed in the three isotypes of multiple myeloma, and the whole blood viscosity was higher in IgA and IgG isotypes with respect to the light chain multiple myeloma ( < 0.001). Moreover, we observed that, as the ISS stage progressed, the albumin/fibrinogen ratio was reduced, and the same hemorheological trend was traced in subgroups with lower albumin levels, higher beta2-microglobulin and red cell distribution width RDW values, and in the presence of a greater bone marrow plasma cell infiltrate.

CONCLUSIONS

Through the changes in blood viscosity in relation to different prognostic factors, this analysis might underline the role of the hemorheological pattern in multiple myeloma.

摘要

背景

在这项单中心研究中,我们回顾性评估了新诊断的多发性骨髓瘤患者的计算血液流变学特征,旨在评估其与一些预后预测指标的可能关系,如国际分期系统(ISS)、白蛋白水平、β2-微球蛋白、红细胞分布宽度和骨髓浆细胞浸润情况。

方法

在一组190例患者中,我们使用德西蒙公式检测计算得出的血液粘度,并检测白蛋白/纤维蛋白原比值作为红细胞聚集的替代指标,然后分别使用克鲁斯卡尔-沃利斯检验和曼-惠特尼检验将这些参数与预后因素相关联。

结果

通过我们的分析发现,多发性骨髓瘤的三种亚型的评估血液流变学模式有所不同,IgA和IgG亚型的全血粘度高于轻链型多发性骨髓瘤(P<0.001)。此外,我们观察到,随着ISS分期进展,白蛋白/纤维蛋白原比值降低,在白蛋白水平较低、β2-微球蛋白和红细胞分布宽度(RDW)值较高的亚组以及骨髓浆细胞浸润较多的情况下,也呈现出相同的血液流变学趋势。

结论

通过与不同预后因素相关的血液粘度变化,该分析可能凸显了血液流变学模式在多发性骨髓瘤中的作用。